Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

$11.22 -0.22 (-1.92%)

High $11.49	Low $11.20	Trades 4,718	Turnover $7,499,551	Volume 664,557
30 June 2023 at 4:12pm

If you were already registered, log in here.

Market Cap (13-Nov) $4,655,044,608 (204th)	Close (30-Jun) $11.22 0 (0%)	Volume (30-Jun) 664,557	Shortsold (9-Nov) 35,408,995 (10.40%) (16th)
52w High $18.22	52w Low $8.26	P/E 178.57	EPS 0.15

Short Interest

ASIC data, 9 Nov 2026

% Shorted

10.40% 0.08

vs 10.49% prior report

Most Shorted Rank

16th

of 711 shorted ASX stocks

Peak Short

16.51%

Apr 2026

Days to Cover

15.7

at 50d avg vol

View full short position history →

	Subject
	TLX TLX Article: Telix boss says Australia ‘horrible’ at getting drugs to patients
	1 (current) 2 3
	TLX TLX Article: Telix upsizes convertibles deal to $650m; delta block clears at $18.70
	TLX TLX Article: Telix shares hit new high on upgraded revenue forecast
	TLX TLX Article: Why $3b Aussie darling Telix needs to grow wings
	TLX TLX Article: ASX posts worst start to year since 2007 as December rally cools
	TLX TLX Article: ASX edges higher; Core Lithium sinks on mine halt; BlueBet jumps 25pc
	TLX TLX Article: ASX edges higher; Core Lithium sinks on mine halt; BlueBet jumps 25pc
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: Proposed issue of securities - TLX
	TLX TLX Ann: Lightpoint Acquisition to Expand Telix Urologic Pipeline
	TLX TLX Ann: Telix Urology Innovation Showcase
	TLX TLX Ann: Phase II study for indication expansion of TLX250-CDx doses
	TLX TLX Article: Why this CEO thinks 454pc growth in his company is just the beginning
	TLX TLX Ann: Appendix 3Y Change in Director Interests - C Behrenbruch
	TLX TLX Ann: Notification regarding unquoted securities - TLX
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: Securities Dealing Policy - updated
	TLX TLX Ann: Results of Annual General Meeting
	TLX TLX Ann: Annual General Meeting - Presentation
	TLX TLX Ann: Annual General Meeting - Chairman and CEO Addresses
	TLX TLX Ann: Notification regarding unquoted securities - TLX
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: ZIRCON Data Presented at AUA Confirms Efficacy in 2cm Masses
	TLX TLX Ann: Proposed issue of securities - TLX
	TLX TLX Ann: Presentation to Accompany AI Development Program Update
	TLX TLX Ann: Telix Accelerates AI Development with Dedicaid Acquisition
	TLX TLX Ann: AGM Notice of Meeting, Proxy Form and Online Guide
	TLX TLX Ann: Q1 2023 Business update to accompany quarterly results
	TLX TLX Ann: Appendix 4C and Activities Report - March 2023 Quarter
	TLX TLX Ann: Telix-Grand Pharma Investor Webcast Notification
	TLX TLX Ann: Telix Preclinical Development of Radiolabelled Olaratumab
	TLX TLX Ann: Notification of upcoming quarterly results and investor call
	TLX TLX Ann: Notification of cessation of securities - TLX
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: Illuccix European Marketing Authorisation Application Update
	TLX TLX Ann: Non-Executive Director Leave of Absence
	TLX TLX Ann: Cleansing Notice
	TLX TLX Ann: Application for quotation of securities - TLX
	TLX TLX Ann: App 3Y Change in Director Interests - T Olson
	TLX TLX Ann: FDA approval of expanded indication of Illuccix in the US
	TLX TLX Ann: Date of 2022 AGM
	TLX TLX Ann: Corporate governance statement - Appendix 4G
	TLX TLX Ann: 2022 Full Year Results Presentation
	TLX TLX Ann: 2022 Full Year Results Release

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Upcoming Floats (8)

MATRIX CRITICAL MINERALS LIMITED

MTX

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Gratifii

MBM

Top

End of Day Prices

Date	Close	Volume	Change
13-Nov	$13.58	877,947	-0.12 (0.88%)
12-Nov	$13.70	2,345,160	-0.32 (2.28%)
11-Nov	$14.02	1,951,626	+0.22 (1.59%)
10-Nov	$13.80	1,305,809	-0.13 (0.93%)
09-Nov	$13.93	1,203,866	+0.26 (1.90%)
06-Nov	$13.67	2,002,751	-0.41 (2.91%)
05-Nov	$14.08	2,586,196	+0.76 (5.71%)
04-Nov	$13.32	1,837,418	+0.32 (2.46%)
03-Nov	$13.00	1,304,985	-0.08 (0.61%)
02-Nov	$13.08	1,418,249	-0.05 (0.38%)
30-Oct	$13.13	1,947,400	-0.35 (2.60%)
29-Oct	$13.48	1,788,720	+0.42 (3.22%)
28-Oct	$13.06	4,042,702	+0.27 (2.11%)
27-Oct	$12.79	2,945,488	-0.06 (0.47%)
26-Oct	$12.85	4,418,896	-0.34 (2.58%)
6 up, 9 down, and 0 flat days

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Telix Pharmaceuticals Health Care Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Telix Pharmaceuticals Health Care
Biotech Canada Cancer Healthcare Medical North America Pharmaceuticals United Kingdom